Status:
UNKNOWN
Neurological Features During COVID19
Lead Sponsor:
Centre d'Investigation Clinique et Technologique 805
Conditions:
Encephalitis
Eligibility:
All Genders
18+ years
Brief Summary
Description of the neurological impairment: clinico-radiological and electrophysilogical correlations
Detailed Description
Describe short and long term clinical radiological and electrophysilogical presentations of neurological damage central and peripheral SARS COV2 infection Describe the association between neurological...
Eligibility Criteria
Inclusion
- PCR SARS COV2 positive or CT Scan
- Central neurological signs such as confusion, epilepsy, abnormal movement, pyramidal signs, motor or sensory deficit, involvement of cranial pairs (such as anomie or ageusia) or peripheral.
- Dysautonomic signs such as hypotension or hypertension, bradycardia or tachycardia, hypothermia, SIADH not explained by therapy or a pathology other than SARS COV 2 infection
Exclusion
- Contraindication to performing an MRI scan
- Minor
- Pregnant woman
- No follow-up possible at 6 months
Key Trial Info
Start Date :
March 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04460599
Start Date
March 8 2020
End Date
September 30 2020
Last Update
July 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Raymond Poincare
Garches, France, 92380